Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
Trial details
- Registry ID
- NCT05054543
- Drugs studied
- Uproleselan
TrialRedline tracks 2 clinical trials sponsored by Apollomics Inc.: 1 Phase 3, 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AMLNCT05054543 | Uproleselan | Terminated | 2024-08-22Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 | APL-101 Oral Capsules | Recruiting | 2026-03-30Estimated |
Names as written in the registry records.